Monette Aujay

Director of Biology and Assay Development at Enliven Therapeutics

Monette Aujay has over 20 years of experience in the pharmaceutical industry. Monette began their career in 1996 as a Research Associate at Recombinant BioCatalysis. Monette then moved to DuPont Pharmaceuticals in 1997, where they held the role of Staff Scientist. In 1999, they joined Rigel Pharmaceuticals Inc. as an Associate Scientist/Scientist. In 2004, they moved to Proteolix as a Scientist. In 2009, they joined Onyx Pharmaceuticals as a Scientist. In 2010, they joined Stemcentrx, Inc. as a Senior Scientist. In 2016, they moved to AbbVie as Associate Director of Assay Development. Currently, they are the Director of Biology and Assay Development at EnLiven Therapeutics.

Monette Aujay attended Penn State University from 1992 to 1996, graduating with a Bachelor of Science (BS) in Cell/Cellular and Molecular Biology.

Location

Boulder, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Enliven Therapeutics

1 followers

Enliven Therapeutics is a biotechnology company focusing on the discovery and development of next generation precision oncology therapeutics.


Employees

11-50

Links